vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and PROSPERITY BANCSHARES INC (PB). Click either name above to swap in a different company.

PROSPERITY BANCSHARES INC is the larger business by last-quarter revenue ($367.6M vs $270.8M, roughly 1.4× HUTCHMED (China) Ltd). PROSPERITY BANCSHARES INC runs the higher net margin — 31.6% vs 0.7%, a 30.9% gap on every dollar of revenue.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...

HCM vs PB — Head-to-Head

Bigger by revenue
PB
PB
1.4× larger
PB
$367.6M
$270.8M
HCM
Higher net margin
PB
PB
30.9% more per $
PB
31.6%
0.7%
HCM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HCM
HCM
PB
PB
Revenue
$270.8M
$367.6M
Net Profit
$2.0M
$116.3M
Gross Margin
37.7%
Operating Margin
-13.2%
Net Margin
0.7%
31.6%
Revenue YoY
-16.5%
Net Profit YoY
-83.6%
-10.7%
EPS (diluted)
$0.00
$1.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
PB
PB
Q1 26
$367.6M
Q4 25
$270.8M
$275.0M
Q3 25
$273.4M
Q2 25
$277.7M
$267.7M
Q1 25
$324.5M
$265.4M
Q4 24
$267.8M
Q3 24
$261.7M
Q2 24
$305.7M
$258.8M
Net Profit
HCM
HCM
PB
PB
Q1 26
$116.3M
Q4 25
$2.0M
$139.9M
Q3 25
$137.6M
Q2 25
$455.0M
$135.2M
Q1 25
$11.9M
$130.2M
Q4 24
$130.1M
Q3 24
$127.3M
Q2 24
$25.8M
$111.6M
Gross Margin
HCM
HCM
PB
PB
Q1 26
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Operating Margin
HCM
HCM
PB
PB
Q1 26
Q4 25
-13.2%
65.1%
Q3 25
64.4%
Q2 25
-1.3%
64.3%
Q1 25
-5.0%
62.7%
Q4 24
62.0%
Q3 24
62.1%
Q2 24
-9.0%
55.2%
Net Margin
HCM
HCM
PB
PB
Q1 26
31.6%
Q4 25
0.7%
50.9%
Q3 25
50.3%
Q2 25
163.8%
50.5%
Q1 25
3.7%
49.1%
Q4 24
48.6%
Q3 24
48.6%
Q2 24
8.4%
43.1%
EPS (diluted)
HCM
HCM
PB
PB
Q1 26
$1.16
Q4 25
$0.00
$1.48
Q3 25
$1.45
Q2 25
$0.52
$1.42
Q1 25
$0.01
$1.37
Q4 24
$1.36
Q3 24
$1.34
Q2 24
$0.03
$1.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
PB
PB
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$8.2B
Total Assets
$1.8B
$43.6B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
PB
PB
Q1 26
Q4 25
$1.4B
Q3 25
Q2 25
$1.4B
Q1 25
$836.1M
Q4 24
Q3 24
Q2 24
$802.5M
Total Debt
HCM
HCM
PB
PB
Q1 26
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Stockholders' Equity
HCM
HCM
PB
PB
Q1 26
$8.2B
Q4 25
$1.2B
$7.6B
Q3 25
$7.7B
Q2 25
$1.2B
$7.6B
Q1 25
$759.9M
$7.5B
Q4 24
$7.4B
Q3 24
$7.4B
Q2 24
$740.1M
$7.3B
Total Assets
HCM
HCM
PB
PB
Q1 26
$43.6B
Q4 25
$1.8B
$38.5B
Q3 25
$38.3B
Q2 25
$1.8B
$38.4B
Q1 25
$1.3B
$38.8B
Q4 24
$39.6B
Q3 24
$40.1B
Q2 24
$1.3B
$39.8B
Debt / Equity
HCM
HCM
PB
PB
Q1 26
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
PB
PB
Operating Cash FlowLast quarter
$8.2M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
1.2%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
PB
PB
Q1 26
Q4 25
$8.2M
$78.3M
Q3 25
$194.8M
Q2 25
$-72.9M
$98.2M
Q1 25
$40.3M
$178.2M
Q4 24
$-205.8M
Q3 24
$274.6M
Q2 24
$-39.8M
$216.5M
Free Cash Flow
HCM
HCM
PB
PB
Q1 26
Q4 25
$3.4M
$68.5M
Q3 25
$185.7M
Q2 25
$-82.2M
$91.8M
Q1 25
$32.5M
$171.1M
Q4 24
$-210.7M
Q3 24
$270.2M
Q2 24
$-49.9M
$211.8M
FCF Margin
HCM
HCM
PB
PB
Q1 26
Q4 25
1.2%
24.9%
Q3 25
67.9%
Q2 25
-29.6%
34.3%
Q1 25
10.0%
64.5%
Q4 24
-78.7%
Q3 24
103.3%
Q2 24
-16.3%
81.8%
Capex Intensity
HCM
HCM
PB
PB
Q1 26
Q4 25
1.8%
3.6%
Q3 25
3.3%
Q2 25
3.3%
2.4%
Q1 25
2.4%
2.7%
Q4 24
1.8%
Q3 24
1.7%
Q2 24
3.3%
1.8%
Cash Conversion
HCM
HCM
PB
PB
Q1 26
Q4 25
4.21×
0.56×
Q3 25
1.42×
Q2 25
-0.16×
0.73×
Q1 25
3.38×
1.37×
Q4 24
-1.58×
Q3 24
2.16×
Q2 24
-1.54×
1.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

PB
PB

Net Interest Income$321.1M87%
Noninterest Income$46.5M13%

Related Comparisons